MetaCap

ArriVent BioPharma Insider Trades

NASDAQ: AVBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

10.52-0.74 (-6.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
1 · $12.98M
Shares bought / sold
0 / 555.55K
Net activity
Net selling $13.0 million

ArriVent BioPharma insider activity

Over the last 12 months, ArriVent BioPharma insiders reported 6 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $13.0 million worth of stock, for net insider selling of $13.0 million. The largest seller was HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD., with $13.0 million in reported sales.

The most recent filing shows LaChapelle Robin (Chief Operating Officer) reporting a transaction in 16,265 shares at $3.65 on Oct 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AVBP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AVBP insider transactions

ArriVent BioPharma insider transactions
DateInsiderTypeSharesValueFiling
Oct 30, 2026LaChapelle RobinChief Operating OfficerOption exercise17,648$110.05KForm 4
Oct 30, 2026LaChapelle RobinChief Operating OfficerOption exercise1,820$4.15KForm 4
Oct 30, 2026LaChapelle RobinChief Operating OfficerOption exercise4,550$10.38KForm 4
Oct 30, 2026LaChapelle RobinChief Operating OfficerOption exercise410$935.42Form 4
Oct 30, 2026LaChapelle RobinChief Operating OfficerOption exercise16,265$59.37KForm 4
Dec 10, 2025HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% OwnerSale555,555$12.98MForm 4
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise6,503$14.83KForm 4
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise2,600$5.93KForm 4
Jul 11, 2025LaChapelle RobinChief Operating OfficerOption exercise2,050$4.67KForm 4
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise12,364$45.13KForm 4
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise2,471$5.63KForm 4
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise7,164$16.33KForm 4
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise2,867$6.54KForm 4
Sep 19, 2024LaChapelle RobinChief Operating OfficerOption exercise2,700$16.85KForm 4
Jan 30, 2024HEALY JAMESDirectorBuy444,444$8.00MForm 4
Jan 30, 2024HEALY JAMESDirectorConversion1,252,308—Form 4
Jan 30, 2024GORDON CARL LDirectorBuy222,222$4.00MForm 4
Jan 30, 2024GORDON CARL LDirectorBuy222,222$4.00MForm 4
Jan 30, 2024GORDON CARL LDirectorConversion469,615—Form 4
Jan 30, 2024GORDON CARL LDirectorConversion469,615—Form 4
Jan 30, 2024GORDON CARL LDirectorConversion821,827—Form 4
Jan 30, 2024GORDON CARL LDirectorConversion821,827—Form 4
Jan 30, 2024ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.DirectorBuy222,222$4.00MForm 4
Jan 30, 2024ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.DirectorBuy222,222$4.00MForm 4
Jan 30, 2024ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.DirectorConversion469,615—Form 4
Jan 30, 2024ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.DirectorConversion469,615—Form 4
Jan 30, 2024ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.DirectorConversion821,827—Form 4
Jan 30, 2024ORBIMED ADVISORS LLC & OrbiMed Capital GP VIII LLC & OrbiMed Advisors IV Ltd & OrbiMed Asia GP IV, L.P.DirectorConversion821,827—Form 4
Jan 30, 2024HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% OwnerBuy555,555$10.00MForm 4
Jan 30, 2024HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% OwnerConversion313,076—Form 4
Jan 30, 2024HILLHOUSE INVESTMENT MANAGEMENT, LTD. & HHLR ADVISORS, LTD.10% OwnerConversion3,616,041—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related